NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Tuesday 20 October 2009

Lonza withdraws Patheon bid, looks elsewhere for formulation

Lonza has withdrawn its $460m bid for Patheon after the major shareholder, JLL, refused to talk. Lonza said it was looking at other opportunities to add formulation capabilities to its portfolio, which it believes fits with its current growth strategy.
Reuters

No comments: